NYSE: AZTR - Azitra Inc

Yield per half year: -78.68%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Azitra Inc

Extended chart Simple chart
Financial Markets by TradingView

About Azitra Inc

Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S.

more details
epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2023-06-16
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://azitrainc.com
Цена ао 0.2002
Change price per day: +14.01% (0.4077)
Change price per week: +12% (0.415)
Change price per month: -10.51% (0.5194)
Change price per 3 month: -15.49% (0.55)
Change price per half year: -78.68% (2.18)
Change price per year: -49.48% (0.92)
Change price per 3 year: 0% (0.4648)
Change price per 5 year: 0% (0.4648)
Change price per 10 year: 0% (0.4648)
Change price per year to date: -6.04% (0.4947)
All parameters

Underestimation

Title Value Grade
P/S 23.81 1
P/BV 5.61 2
P/E 0 0
EV/EBITDA -1.44 0
Total: 3.75

Efficiency

Title Value Grade
ROA, % -220.58 0
ROE, % -387.34 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.083 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 523.64 10
Yield Ebitda, % 21.29 4
Yield EPS, % 3955.92 10
Total: 6.4
More

Institutions Volume Share, %
Precept Management LLC 50000 0.41
Knollwood Investment Advisory, LLC 41537 0.34
Warberg Asset Management LLC 35000 0.29
Citadel Advisors Llc 28942 0.24
Millennium Management LLC 22427 0.19
Blackrock Inc. 4209 0.03
UBS Group AG 145 0
Wells Fargo & Company 11 0



Head Job title Payment Year of birth
Mr. Francisco D. Salva President, CEO & Director 427.03k 1971 (54 years)
Mr. Norman Staskey CFO, Treasurer & Secretary 314.02k 1970 (55 years)
Mr. Travis M. Whitfill M.P.H., Ph.D. Co-Founder, COO & Director 161.61k 1990 (35 years)

Address: United States, Branford. CT, 21 Business Park Drive - open in Google maps, open in Yandex maps
Website: https://azitrainc.com